Long noncoding RNAs (lncRNAs) have recently emerged as a major class of regulatory
molecules, which were involved in a broad range of biological processes and complex …

Accumulating evidence demonstrates that long non-coding RNAs (LncRNAs) play important
roles in regulating gene expression and are involved in various cancers, including colorectal …

Increasing evidence suggests that long non-coding RNAs (lncRNAs) are aberrantly
expressed in colorectal cancer (CRC); however, only few CRC-related lncRNAs have been …

Colorectal cancer is one of the top-ranked human malignancies. The development and
progression of colorectal cancer are associated with aberrant expression of multiple coding …

Colorectal cancer (CRC) is one of the most common cancers globally. Although a variety of
CRC screening methods have been developed, many patients are diagnosed at advanced …

Colorectal cancer (CRC) is one of the most common cancers in the world; therefore,
extensive research is needed to find new molecular therapeutic targets and biomarkers …

Long non‐coding RNAs (lncRNAs) have potential applications in clinical diagnosis and
targeted cancer therapies. However, the expression profile of lncRNAs in colorectal cancer …

Long non-coding RNAs (lncRNAs) serve critical roles in cancer development and
progression. Herein, through next generation RNA sequencing and experimental …

Colorectal cancer (CRC) is the fourth most common cause of death worldwide. Surgery is
usually the first line of treatment for patients with CRC but many tumors with similar …

Colorectal cancer (CRC) is the primary cause of cancer-related death worldwide; however,
specific and sensitive tools for the early diagnosis and targeted therapy of CRC are currently …